Qiming Venture Partners
Qiming Venture Partners is a venture capital firm investing in the TMT and healthcare industries at the early and growth stages.
Business Model:
Revenue: $8.1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Qiming Venture Partners Information
Geographic Data
Address: Room3906 Jinmao Tower
City: Shanghai
State: shanghai municipality
Zip: 200121
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$9B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
2,312,265Website Global Rank
8,132Website Monthly Traffic
Twitter Followers
Description
Qiming Venture Partners is a venture capital firm that specializes in building new companies in China. Since their establishment, they have been investing in the TMT and healthcare industries at the early and growing stages. Founded in 2006 by Gary Rieschel, Qiming Venture Partners based in Shanghai, Shanghai.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2010 | Sangon Biotech | Series A | 6.2M |
| 1/2018 | Chushou | Series D | 47.5M |
| 2/2017 | Anxin Doctor | Series B | 29.1M |
| 2/2017 | Anssure Pharma | Series A | 8.7M |
| 3/2008 | Touchmedia | Series B | 14.2M |
| 4/2020 | Belief Biomed | Series B | 84M |
| 2/2021 | Saints Sages Medical | Series A | 18.6M |
| 9/2017 | VR Medical | Series B | 3M |
| 9/2019 | Tisenc | Series B | 11.2M |
| 3/2015 | Insta360 | Series A | 8M |
| 11/2021 | Micropace | Series A | 5.5M |
| 8/2006 | Touchmedia | Series A | - |
| 4/2021 | Unisound | Series D | 60M |
| 8/2018 | APT Medical | Series B | 11.1M |
| 1/2005 | Gammastar Medical Group | Series A | 8.7M |
| 5/2021 | IntoCare | Series D | 43.2M |
| 8/2018 | Cool Math | Series A | 10M |
| 11/2021 | Beijing Okeanos Technology | Series B | 22.4M |
| 5/2010 | ChinaCache | Post-IPO Equity | - |
| 5/2021 | Data Transmission Group | Secondary Market | 9.3M |
| 10/2013 | Dajiabao | Series A | - |
| 12/2017 | Cehome | Series D | 44M |
| 8/2021 | Superhexa | Seed Round | 9.9M |
| 12/2021 | Superhexa | Series A | 28M |
| 8/2022 | Oricell Therapeutics | Series B | 120M |
| 12/2013 | Shanghai Rendu Biotechnology | Series B | 10.3M |
| 9/2007 | Juren Educational | Venture Round | 20M |
| 10/2017 | SGEET | Series A | 7.5M |
| 7/2018 | ZEGOCLOUD | Series B | 16M |
| 5/2014 | Meitu | Series B | 115M |
| 12/2019 | Yuanxin Huibao | Series A | 4.3M |
| 8/2017 | Kintep Environmental | Series B | 5.6M |
| 5/2013 | Cehome | Series A | 2M |
| 5/2021 | MeetFuture China | Series A | 12.3M |
| 6/2011 | Novast | Series C | 2.9M |
| 10/2016 | Broncus Technologies | Series A | 12.2M |
| 1/2021 | Oricell Therapeutics | Series A | 0 |
| 4/2015 | HaiRun Pictures | Series A | 11.3M |
| 11/2010 | Guokang Health Management | Series B | 14.9M |
| 1/2021 | RFoneTech | Series A | 4.6M |
| 12/2017 | Xiaobu | Series B | 14M |
| 9/2011 | Novast | Series D | 2M |
| 10/2021 | Clounix | Seed Round | 34.9M |
| 5/2021 | Render | Series A | 15.5M |
| 8/2018 | Plum | Series B | 21.4M |
| 8/2019 | Haoyiku | Series C | 100M |
| 10/2017 | Gaiya Environment | Series A | 6.1M |
| 4/2015 | Fortune International Factoring | Series A | 16.2M |
| 5/2018 | Hanqi | Series A | 6.3M |
| 7/2019 | Chuman | Series B | 8.7M |
| 11/2017 | Chuman | Series A | 8.3M |
| 2/2021 | Singular Medical | Series B | 24M |
| 4/2017 | IntoCare | Series A | 26M |
| 2/2021 | Morewis | Series B | 9.3M |
| 12/2011 | Appconomy | Series B | 10M |
| 12/2021 | InfStones | Series B | 33M |
| 9/2009 | 60DXchange | Venture Round | - |
| 6/2017 | SinoTau | Series B | 22M |
| 4/2021 | P&a;R Measurement Technology | Series C | 23.9M |
| 2/2018 | P&a;R Measurement Technology | Series A | 9.9M |
| 12/2021 | TUNGEE | Series B | 0 |
| 7/2010 | LanzaTech | Series B | 18M |
| 12/2019 | Oricell Therapeutics | Seed Round | 14.2M |
| 4/2017 | CanSinoBIO | Series E | 0 |
| 1/2020 | DST Car | Series C | - |
| 3/2020 | Singular Medical | Series A | 10M |
| 8/2018 | Kira Pharmaceuticals | Series A | 13M |
| 11/2020 | LaNova Medicines | Series A | 84.4M |
| 10/2018 | DST Car | Series B | 47.4M |
| 3/2022 | MeetFuture China | Series B | 0 |
| 7/2020 | Antengene Corporation | Series C | 97M |
| 3/2016 | Cehome | Series C | 25M |
| 1/2017 | Diandoc | Seed Round | 1M |
| 9/2017 | TigerGraph | Series A | 31M |
| 8/2016 | Ruhnn Holding Limited | Series C | - |
| 2/2017 | LIH Investment &a; Management | Series A | 5.8M |
| 9/2009 | Jiayuan | Series B | - |
| 5/2018 | Xueba100.com | Series D | 22.5M |
| 2/2009 | Youxigu | Series A | - |
| 9/2015 | Oakbarrel | Series B | 3.1M |
| 10/2010 | Dang Le | Series A | 12M |
| 11/2018 | Eigen | Series B | 6.6M |
| 12/2018 | Try Try | Series A | 7M |
| 4/2016 | AirQuality | Series B | 4M |
| 4/2017 | ByteDance | Series D | 1B |
| 7/2020 | 52toys | Secondary Market | 2M |
| 3/2019 | 52toys | Series A | 447.3k |
| 3/2018 | 52toys | Series A | 14.6M |
| 4/2020 | DiNovA Medtech | Series C | 17M |
| 6/2016 | JunHe | Series B | 7.6M |
| 8/2014 | Lagou | Series B | 25M |
| 12/2020 | dMed | Series C | 100M |
| 12/2016 | dMed | Series A | 8M |
| 10/2012 | MOGU | Series C | - |
| 4/2018 | ZD Medical | Series A | 16.7M |
| 7/2021 | Hochuen Medical Technology | Series A | 6.2M |
| 1/2012 | MOGU | Series B | 10M |
| 4/2017 | ZappRx | Series B | 25M |
| 11/2021 | Genlight | Series B | 31.4M |
| 7/2018 | The Good Stuff | Series B | 50M |
| 12/2015 | Aerospace Environment | Series A | 1.3M |
| 12/2019 | Chaodian Culture | Series B | 150M |
| 10/2021 | Brise Pharma | Angel Round | 0 |
| 11/2010 | Docin | Series B | - |
| 12/2008 | Docin | Series A | 1M |
| 1/2020 | Sunny Dental | Series A | 28.7M |
| 6/2015 | Financial Information Management | Series A | 6M |
| 6/2017 | Chaitin Tech | Series A | 4M |
| 6/2019 | Pulsar Technology | Series A | - |
| 12/2018 | Chaodian Culture | Series A | 5.5M |
| 12/2016 | CETA | Series A | 4.4M |
| 3/2016 | CashBUS | Series B | 25M |
| 3/2018 | Bouffalo Lab | Series A | 7M |
| 10/2017 | Castbox | Series A | 12.8M |
| 1/2018 | Innostic | Series A | 39.5M |
| 8/2020 | Shukun Technology | Series B | 0 |
| 9/2013 | Tiangua Online | Series B | 1M |
| 4/2021 | Xizi Education | Series A | 22M |
| 5/2021 | Just Medical | Series B | 34M |
| 10/2015 | JFK Biotech | Angel Round | 472.7k |
| 8/2019 | Bondent Technology | Series D | - |
| 6/2020 | Shukun Technology | Series B | 0 |
| 12/2009 | CITIC Pharmaceutical | Series D | 1M |
| 3/2021 | Fucunbao | Series C | 11.4M |
| 6/2018 | RENS Energy | Angel Round | 1M |
| 7/2017 | Kuaile Zhihui | Series A | 0 |
| 2/2015 | Aerospace Environment | Series A | - |
| 4/2020 | New Horizon Health | Series D | 20M |
| 9/2021 | GYENNO Technologies | Series B | 17.3M |
| 2/2016 | Transwarp | Series B | 23.6M |
| 1/2015 | Transwarp | Series A | 5.1M |
| 6/2022 | LaNova Medicines | Series B | - |
| 11/2020 | Kira Pharmaceuticals | Venture Round | - |
| 9/2019 | Yunyinggu | Series C | 22M |
| 10/2016 | APT Medical | Series A | 3.6M |
| 8/2019 | APT Medical | Venture Round | 27.2M |
| 11/2018 | APT Medical | Series C | 19.2M |
| 3/2015 | Ark Biosciences | Series A | - |
| 11/2021 | Suci Technology | Series A | 8.3M |
| 10/2012 | CooTek | Series B | 8.2M |
| 6/2021 | Insilico Medicine | Series C | 0 |
| 12/2015 | Nurotron Biotechnology | Series C | - |
| 6/2011 | Domob | Series B | 20M |
| 4/2018 | Castbox | Series B | 13.5M |
| 4/2020 | Yunyinggu | Series C | 28.2M |
| 4/2020 | Chuhang Tech | Series A | 6.4M |
| 5/2021 | Hope Medicine | Series B | 56M |
| 10/2015 | Luoji Siwei | Series B | - |
| 11/2021 | Shanzhen | Series D | 17M |
| 9/2019 | Shanzhen | Series D | 30M |
| 4/2021 | Sincere Edu | Series A | 13M |
| 5/2022 | AskGene Pharma | Series A | 20M |
| 12/2018 | YI Technology | Venture Round | 10M |
| 4/2015 | UBTech Robotics | Series A | - |
| 7/2016 | UBTech Robotics | Series B | 100M |
| 11/2020 | Nice Tuan | Series C | 0 |
| 5/2011 | Crown Bioscience | Venture Round | 1M |
| 4/2012 | Dang Le | Series B | 20M |
| 5/2015 | MedSci | Series A | 14.9M |
| 7/2020 | TUNGEE | Series B | 17.2M |
| 3/2020 | NVX Clouds Tech | Series A | 3.9M |
| 11/2021 | Atom Semiconductor | Venture Round | 12M |
| 4/2020 | Pratilipi | Series C | 0 |
| 4/2018 | Miaoshou Doctor | Series C | 79.6M |
| 4/2022 | Onechip Bioelectronics | Series B | 23.5M |
| 8/2019 | Webuy Group | Series C | 100M |
| 9/2016 | Meituan Bike | Series C | - |
| 9/2018 | Tuhu | Series E | 0 |
| 8/2018 | Chaodian Culture | Angel Round | - |
| 6/2017 | Meituan Bike | Series E | 600M |
| 5/2015 | Tongdun Technology | Series B | 30M |
| 1/2017 | Meituan Bike | Series D | 215M |
| 11/2020 | ZEGOCLOUD | Venture Round | 50M |
| 1/2021 | Yunji Technology | Series C | 0 |
| 2/2022 | BUD | Series A | 15M |
| 8/2017 | ARMO BioSciences | Series C | 0 |
| 3/2021 | Hangzhou Weier | Series B | 15.5M |
| 12/2009 | ChinaCache | Series D | - |
| 9/2015 | Roborock | Angel Round | - |
| 3/2016 | SharpSpring | Post-IPO Equity | - |
| 1/2012 | Timesafer | Series A | - |
| 4/2007 | ChinaCache | Series B | 31.5M |
| 4/2021 | Tasogare | Series B | 41.1M |
| 5/2021 | TUNGEE | Venture Round | 148M |
| 5/2019 | Chuhang Tech | Series A | 4.5M |
| 11/2021 | Zeen Health | Venture Round | 6.3M |
| 4/2018 | Chaodian Culture | Series A | 12.6M |
| 3/2007 | PPS | Series B | 10M |
| 12/2017 | Mafengwo | Series D | 133M |
| 12/2013 | Nurotron Biotechnology | Series C | 16.2M |
| 10/2018 | Akulaku | Series C | 0 |
| 6/2007 | ICE Entertainment | Series A | 8.5M |
| 6/2020 | OriginCell | Series A | 8.4M |
| 7/2018 | AI Prime | Angel Round | 1M |
| 7/2022 | Biotree | Series A | 13.3M |
| 5/2019 | New Horizon Health | Series C | 0 |
| 3/2021 | Newsoara | Series C | 7M |
| 6/2020 | Biren Technology | Series A | 0 |
| 12/2016 | Cencorp Automation | Series A | 10.5M |
| 7/2018 | Core Medical | Series A | 4.4M |
| 7/2012 | Beijing Centre Biology | Series B | 2.6M |
| 10/2019 | Casela | Series A | 16.7M |
| 1/2022 | Deep View Technology | Series B | - |
| 3/2021 | Medilink Therapeutics | Series A | 50M |
| 5/2021 | Yidao Biotechnology | Series C | 61.8M |
| 6/2015 | Shenogen Pharma Group | Series D | 2.1M |
| 12/2019 | DiNovA Medtech | Series C | 24.6M |
| 11/2019 | Liuyi Jiaoyu | Series B | 0 |
| 7/2022 | CIX Technology | Seed Round | - |
| 5/2019 | LetsGetChecked | Series B | 0 |
| 3/2019 | Insta360 | Series C | 0 |
| 9/2022 | Supervision Technology | Seed Round | - |
| 4/2016 | FraudMetrix | Series C | - |
| 11/2021 | Tripod Preclinical Research Laboratories | Venture Round | 0 |
| 5/2017 | Jisuyun | Series A | 7.4M |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 6/2020 | Kingsware | Series A | 14.7M |
| 9/2021 | XSKY Data Technology | Series E | 0 |
| 3/2021 | Delta Medical | Series E | 20.1M |
| 8/2019 | Delta Medical | Series C | 7.1M |
| 5/2022 | Point One | Series B | 36.8M |
| 12/2016 | ANXIN | Series B | 42.7M |
| 6/2016 | AIQI Technology | Venture Round | 7M |
| 7/2021 | Liangyihui | Series C | 55.9M |
| 11/2019 | Nice Tuan | Series B | 60.4M |
| 10/2021 | Cubenergy Technology | Series A | - |
| 4/2012 | ITutorGroup | Series A | 15M |
| 8/2012 | CooTek | Series A | 4.2M |
| 8/2015 | Linjia.me | Series B | - |
| 12/2021 | Gemsouls | Series A | 4M |
| 1/2021 | Erwan Technology | Series D | - |
| 3/2021 | YUANBAO TECH | Series C | 80M |
| 12/2014 | LanzaTech | Series D | 0 |
| 2/2021 | Plum | Series B | 9.1M |
| 1/2022 | MKSEMI | Pre-Series A | 12.8M |
| 8/2019 | Huimei Technology | Series C | 30M |
| 11/2013 | LanzaTech | Series C | 0 |
| 8/2021 | WeRide | Secondary Market | 2M |
| 8/2017 | ABC Fintech | Series A | 30M |
| 5/2017 | CANbridge Pharmaceuticals | Series B | 25M |
| 5/2015 | Coohua | Series B | 20M |
| 7/2015 | Bilibili | Series C | 161.4M |
| 10/2016 | Bondent Technology | Series A | 9M |
| 9/2007 | Gaoxing Co., Ltd | Series A | - |
| 10/2013 | Unisound | Series A | 16.3M |
| 3/2021 | Casela | Series A | 2.8M |
| 3/2020 | Berry Oncology | Series A | 10M |
| 12/2021 | PoPop World | Seed Round | 0 |
| 1/2021 | Cornerstone Robotics | Series A | 17M |
| 3/2021 | MediLink-Global | Series A | 36.9M |
| 1/2015 | APUS Group | Series B | 100M |
| 2/2022 | Purui | Seed Round | 15.7M |
| 11/2006 | Kuwo Science and Technology | Series A | 5.5M |
| 5/2011 | Gan &a; Lee Pharmaceutical | Series B | 30.2M |
| 4/2021 | ZSHK Laboratories | Series A | 15.5M |
| 2/2012 | Gan &a; Lee Pharmaceutical | Series B | - |
| 8/2010 | BTR | Series A | 1.6M |
| 1/2020 | DST Car | Series C | - |
| 6/2013 | Venus MedTech | Series A | 17M |
| 9/2017 | Zaojiu | Series A | 5.2M |
| 3/2018 | Zaojiu | Series A | 4.7M |
| 6/2009 | Taomee | Series A | - |
| 8/2018 | CureGenetics | Series A | 17M |
| 1/2019 | V Light | Series A | 2.5M |
| 9/2021 | V Light | Series A | 7M |
| 12/2019 | Woof | Series A | 7M |
| 12/2018 | Woof | Series A | 5.8M |
| 4/2017 | Bomming Vision | Series A | 4.4M |
| 1/2018 | Bomming Vision | Series A | 1.5M |
| 5/2014 | VINNO Technology | Series B | 7.7M |
| 5/2018 | Tisenc | Series A | 6.3M |
| 3/2005 | b2c.cn | Series A | 3M |
| 2/2023 | Hochuen Medical Technology | Series B | - |
| 5/2018 | Philm | Series B | 7M |
| 10/2014 | Coohua | Series A | 4.9M |
| 12/2007 | Topone | Series C | 50M |
| 3/2013 | JHT TCM Clinics | Series A | 2.2M |
| 9/2021 | PlusLife Biotech | Series A | 14.9M |
| 1/2007 | Tianyuan Bio-Pharmaceutical | Series A | - |
| 10/2018 | WeRide | Series A | - |
| 7/2021 | NEIWAI | Series D | 100M |
| 10/2019 | NEIWAI | Series C | 18M |
| 3/2015 | BBI Life Sciences | Post-IPO Equity | 10.3M |
| 9/2019 | QwikMatch | Debt Financing | 1.4M |
| 1/2017 | CooTek | Series D | 66M |
| 5/2017 | ET Healthcare | Venture Round | 7M |
| 4/2015 | Zai Lab | Series A | 18.3M |
| 3/2019 | Gohoo | Series A | 10.6M |
| 11/2015 | Zhihu | Series C | 55M |
| 2/2015 | Helijia | Series C | 50M |
| 8/2022 | Insilico Medicine | Series D | 35M |
| 11/2019 | 61Draw.com | Series B | 11M |
| 1/2023 | Insyce | Series B | 21.8M |
| 8/2013 | LP Amina | Series C | 20M |
| 1/2017 | Bondent Technology | Series B | - |
| 2/2008 | Ether Optronics (Suzhou) Co., Ltd. | Venture Round | - |
| 9/2017 | SinoVision Technologies | Series B | 29M |
| 8/2019 | TUNGEE | Series B | 17.7M |
| 2/2014 | VANCL | Series G | 100M |
| 1/2021 | Erwan Technology | Series E | - |
| 7/2017 | Qiagen Suzhou Translational Medicine | Series A | 0 |
| 10/2019 | Club Factory | Series D | 100M |
| 7/2015 | OneAPM | Series C | 26.7M |
| 11/2021 | Cornerstone Robotics | Series B | 0 |
| 7/2018 | Lanjinrong | Series C | 11.6M |
| 3/2018 | Infervision | Series B | 47.4M |
| 6/2019 | 61Draw.com | Series B | 28M |
| 5/2022 | Yike Polymers | Series B | - |
| 6/2018 | IDsManager | Series A | 7.8M |
| 9/2021 | Alamar Biosciences | Series B | 80M |
| 1/2015 | Mitralign | Series E | 23M |
| 12/2021 | Wholee | Series B | 69M |
| 2/2022 | NFTGo | Pre-Series A | 6.8M |
| 5/2020 | Nice Tuan | Series C | 0 |
| 11/2018 | Chushou | Venture Round | 8.4M |
| 1/2022 | Axera | Series A | 0 |
| 7/2017 | Bingobox | Series A | 14.7M |
| 5/2021 | Insight Lifetech | Secondary Market | 18.1M |
| 1/2018 | Bingobox | Series B | 0 |
| 1/2017 | Chushou | Series C | 57.6M |
| 5/2013 | CSD E.P. Water Service | Series B | - |
| 9/2016 | Zuiyou | Series B | 53M |
| 2/2013 | Tujia | Series B | 40M |
| 4/2022 | LTZ Therapeutics | Pre-Series A | 17M |
| 5/2022 | Ashermed | Series B | - |
| 6/2008 | LP Amina | Series A | 5M |
| 9/2019 | Platelet BioGenesis | Series A | 26M |
| 9/2017 | Lagou | Series D | 119.2M |
| 11/2018 | Chomp Cloud | Series B | 13.3M |
| 4/2021 | ET Healthcare | Series G | 105M |
| 5/2020 | Microtech Medical | Venture Round | 20M |
| 9/2020 | Delta Medical | Series D | - |
| 6/2015 | Zhejiang JFK | Angel Round | - |
| 6/2018 | Alpha Biopharma | Series A | 37M |
| 4/2014 | Laguo | Series A | 5M |
| 10/2018 | DST Car | Series B | 43.1M |
| 8/2014 | Zai Lab | Series A | 10M |
| 6/2014 | Zhihu | Series B | 22M |
| 1/2023 | Tingsheng Technology | Series B | 14.7M |
| 8/2017 | SceneRay | Series C | 19.1M |
| 9/2018 | ET Healthcare | Series C | 17.5M |
| 8/2016 | Xiaoman Technology | Series B | 5.3M |
| 12/2019 | Vongi | Series B | 2.9M |
| 5/2009 | Touchmedia | Series B | 16.2M |
| 10/2017 | WeRide | Seed Round | - |
| 7/2019 | OneAPM | Venture Round | 1.6M |
| 7/2014 | Beijing Richen-Force Science &a; Technology | Series B | 4.5M |
| 7/2017 | AFU | Series C | 9.3M |
| 12/2021 | Xinchuangyuan Semiconductor | Series A | 75.4M |
| 12/2021 | Yunji Technology | Venture Round | 72.2M |
| 3/2020 | Berry Genomics | Post-IPO Equity | 10M |
| 5/2021 | Wonderful | Secondary Market | 1.4M |
| 4/2018 | Bondent Technology | Series C | 12.7M |
| 1/2012 | Qiniu | Series A | - |
| 7/2018 | Zuiyou | Series C | 22M |
| 3/2021 | Zhenge Biotech | Series B | 70M |
| 7/2016 | Chaitin Tech | Series A | 4.1M |
| 9/2017 | Infervision | Series B | 18.2M |
| 10/2021 | Qingflow | Series B | 11.8M |
| 12/2015 | UBTech Robotics | Series A | 20M |
| 12/2017 | Eigen | Series B | 18.5M |
| 1/2008 | Crown Bioscience | Venture Round | - |
| 9/2019 | DST Car | Venture Round | 30M |
| 3/2018 | Frontage Laboratories | Funding Round | 32.4M |
| 3/2020 | IntoCare | Series C | 7M |
| 5/2017 | XSKY Data Technology | Series B | 17.4M |
| 3/2020 | CureGenetics | Series A | 9.5M |
| 11/2007 | Dining Secretary | Series B | - |
| 9/2021 | moodytiger | Series B | 20M |
| 8/2018 | CANbridge Pharmaceuticals | Series C | 38.1M |
| 7/2019 | Xiudan | Seed Round | - |
| 1/2019 | Zion Pharma | Series A | 11.9M |
| 8/2020 | Zion Pharma | Series A | 20M |
| 12/2014 | Unisound | Series B | 50M |
| 4/2017 | Berry Genomics | Funding Round | 8.1M |
| 2/2019 | Nuvaira | Equity | 79M |
| 7/2016 | CooTek | Series D | 46M |
| 6/2019 | ZD Medical | Series A | 4.5M |
| 9/2018 | IntoCare | Series B | 3.7M |
| 6/2014 | Inbilin | Series A | 15M |
| 9/2021 | Genevide | Angel Round | 6M |
| 4/2019 | WebComics | Venture Round | 785k |
| 12/2020 | Compart Systems | Venture Round | 398M |
| 1/2014 | Tuhu | Series B | - |
| 8/2010 | 2Duche | Venture Round | - |
| 9/2018 | Bion Interactive Entertainment Company | Seed Round | 2M |
| 3/2008 | Crown Bioscience | Series B | 3.2M |
| 8/2018 | PangQiu | Series A | 6.1M |
| 1/2018 | Berry Genomics | Post-IPO Equity | 122.7M |
| 6/2013 | Iron Armour | Series A | 5M |
| 8/2021 | Houmo.AI | Seed Round | 46M |
| 11/2012 | YPX Cayman Holdings | Series C | 0 |
| 7/2021 | Kingsware | Series B | 42.4M |
| 5/2021 | MKSEMI | Series A | 12.9M |
| 2/2015 | Amoy Diagnostics | Series A | 10.7M |
| 1/2014 | VR Medical | Series A | 5.5M |
| 6/2009 | Alltech Medical Systems | Series B | 5M |
| 5/2017 | Jisuyun | Series A | 7.4M |
| 3/2014 | Domob | Series C | 2M |
| 1/2010 | eHi Car Rental | Series B | 18.7M |
| 4/2019 | Anxin Doctor | Series B | 3.6M |
| 9/2017 | Sino Vision | Series B | 30.6M |
| 8/2011 | Arrail Dental Clinic | Series B | 20M |
| 5/2014 | Ants Technology | Series A | 3.5M |
| 3/2016 | Shanghai Rendu Biotechnology | Series B | 2.3M |
| 8/2018 | Jacobio Pharmaceuticals | Series C | 0 |
| 11/2016 | Yinshiji | Series A | - |
| 3/2010 | Tigermed | Venture Round | 2M |
| 2/2014 | Wacai.com | Series A | 15M |
| 2/2019 | Xiaobu | Series B | 12M |
| 4/2019 | Bomming Vision | Series A | 596k |
| 7/2016 | KingTrol Data | Series A | 4.5M |
| 3/2016 | SMTP Technology | Series A | 3.1M |
| 1/2015 | Zhaolu Tianxia Wang | Series A | 1.6M |
| 7/2016 | Junhetang | Series B | 7.9M |
| 1/2016 | AIQI Technology | Series A | - |
| 11/2016 | Chomp Cloud | Series A | 6M |
| 3/2008 | eHi Car Rental | Series A | 5M |
| 7/2015 | CMLabs | Series A | 1.1M |
| 1/2016 | 8kana | Series A | 6M |
| 9/2006 | Alltech Medical Systems | Series A | - |
| 11/2015 | Shanghai Keysino Separation Technology | Series A | 7.9M |
| 12/2010 | wali | Series A | 4.6M |
| 7/2014 | CooTek | Series C | 69.3M |
| 3/2011 | CSD Beijing Water Affairs Op | Venture Round | - |
| 6/2014 | Ants Technology | Series B | 7M |
| 6/2009 | ConvenientPower HK | Series A | 3M |
| 9/2014 | Tuhu | Series B | 10M |
| 3/2019 | Emergen | Series B | 29.8M |
| 4/2014 | APT Medical | Series A | - |
| 1/2018 | Roborock | Series B | 3.4M |
| 3/2020 | Wuli Planet | Series A | 7.5M |
| 6/2018 | Wuli Planet | Seed Round | 2M |
| 4/2020 | Shulan Health | Series C | 8.5M |
| 4/2016 | Roborock | Series B | 25M |
| 1/2017 | Connect Biopharmaceuticals | Series A | 20M |
| 7/2018 | Kaiheikeji Digital | Series A | 15M |
| 11/2017 | Kaiheikeji Digital | Series A | 11.5M |
| 1/2011 | CSD E.P. Water Service | Venture Round | - |
| 2/2020 | Fingo | Series A | 7M |
| 4/2017 | Qiang Sen International Community Medical | Series B | 14.6M |
| 8/2010 | Jiayuan | Series B | - |
| 9/2016 | Hypereal | Series B | 10.5M |
| 7/2020 | HashQuark | Series A | 2M |
| 1/2018 | Chaodian Culture | Seed Round | 723.8k |
| 5/2015 | Junhetang | Series B | - |
| 10/2018 | DK MedTech | Series B | 8.7M |
| 6/2016 | VeeR (Velocious) | Seed Round | 2M |
| 8/2019 | WorkTrans | Series C | 50.5M |
| 9/2011 | Slanissue | Venture Round | 10M |
| 5/2019 | Hesai Technology | Series C | 37M |
| 8/2022 | Prismlab China Ltd | Series C | 29.1M |
| 9/2016 | OneAPM | Series D | 19.5M |
| 2/2010 | Aeonmed Medical Treatment | Series A | 3.5M |
| 10/2017 | Moretickets | Series B | 25M |
| 6/2017 | Platelet BioGenesis | Series A | 0 |
| 7/2018 | Wacai.com | Series D | 140M |
| 5/2019 | Mafengwo | Series E | 0 |
| 9/2021 | Sanegene Bio | Series A | 38M |
| 2/2020 | Jacobio Pharmaceuticals | Series C | 27M |
| 5/2008 | Kuwo Science and Technology | Series B | - |
| 7/2014 | Intelligent Automation | Series B | 4.2M |
| 4/2009 | Kaixin001 | Series B | 20M |
| 1/2008 | PPS | Series C | 20M |
| 8/2008 | VANCL | Series D | 30M |
| 12/2016 | Luo Tianyi | Series B | 8M |
| 3/2015 | Venus MedTech | Series B | 8M |
| 9/2017 | Venus MedTech | Series C | 7.4M |
| 11/2020 | Yunyinggu | Series D | 45.6M |
| 5/2021 | Health Biotech | Series B | 34.5M |
| 11/2017 | Bioscience | Series C | 15.6M |
| 7/2017 | Kira Pharmaceuticals | Series A | 5M |
| 9/2021 | WOWJOY TECHNOLOGY | Series A | 13.6M |
| 3/2022 | ACXEL Tech | Seed Round | 0 |
| 10/2011 | YPX Cayman Holdings | Series B | 20M |
| 5/2021 | TUNGEE | Series C | 148M |
| 2/2022 | WOWJOY TECHNOLOGY | Series A | 10M |
| 5/2017 | Vongi | Series A | 6M |
| 6/2021 | Xiaoe Tech | Series D | 120M |
| 6/2015 | SMTP Technology | Series A | 8.1M |
| 5/2018 | The Makers | Series B | 8.5M |
| 3/2018 | Chaonengjie | Seed Round | 2.8M |
| 12/2009 | LP Amina | Series B | 9.4M |
| 3/2013 | Sino MDT | Series A | 4M |
| 5/2018 | Sino Biological | Venture Round | 15.8M |
| 2/2012 | Shanghai Tellgen Life Science | Series A | 5M |
| 4/2007 | Jiayuan | Series A | 5.4M |
| 4/2021 | Zion Pharma | Series B | 37M |
| 4/2016 | Tiebaobei | Series C | 30.9M |
| 9/2018 | Cubenergy Technology | Series A | 7.3M |
| 3/2020 | Structure Therapeutics | Series A | 26M |
| 3/2015 | CashBUS | Series A | - |
| 4/2021 | Castbox | Series C | 15M |
| 7/2016 | LIH Investment &a; Management | Series A | 12M |
| 8/2018 | Koala Reading | Series B | 20M |
| 8/2014 | Laguo | Series B | 25M |
| 9/2017 | ABC Fintech | Series A | 30M |
| 3/2018 | ACEA BIO | Series E | 15M |
| 2/2020 | Kira Pharmaceuticals | Series B | 28M |
| 12/2021 | DP Technology | Series B | 43.7M |
| 4/2016 | CanSinoBIO | Venture Round | 11M |
| 3/2018 | Jisuyun | Series B | 11.4M |
| 12/2009 | Gan &a; Lee Pharmaceutical | Series A | 16.2M |
| 12/2017 | Koala Reading | Series A | 10M |
| 11/2018 | Reelsky Data Systems | Series A | 5.4M |
| 4/2021 | ROX Motor | Series A | 60M |
| 2/2012 | Touchmedia | Series C | 16.2M |
| 12/2018 | FirstGrid | Seed Round | 4.8M |
| 7/2014 | MEGVII | Series B | 22M |
| 3/2022 | BlockVision | Seed | 5M |
| 7/2022 | Chatail | Series B | 10M |
| 1/2018 | Xiaoman Technology | Series C | 9.7M |
| 4/2016 | Tongdun Technology | Series B | 32M |
| 11/2018 | Haoyiku | Series B | - |
| 4/2021 | Booming Technologies | Series C | 56M |
| 5/2019 | Nice Tuan | Series A | 27.9M |
| 1/2020 | Nice Tuan | Series B | 88.3M |
| 8/2022 | DeepWay | Series A | 67.2M |
| 5/2011 | Crown Bioscience | Series C | 28.8M |
| 2/2021 | Miaoshou Doctor | Series E | 0 |
| 6/2013 | Intelligent Automation | Series A | 5.1M |
| 1/2016 | Zai Lab | Series B | 106.2M |
| 8/2017 | Chomp Cloud | Series A | 7M |
| 6/2012 | Forgame | Private Equity Round | 68.8M |
| 5/2010 | 7k7k.com | Angel Round | 1.1M |
| 5/2022 | BUD | Series B | 0 |
| 12/2017 | Meituan Bike | Corporate Round | - |
| 8/2019 | RedDoorz | Series C | 0 |
| 7/2018 | Qingqi Technology | Angel Round | - |
| 11/2018 | Guji Information | Angel Round | 287.9k |
| 5/2010 | Mutto Optronics | Venture Round | - |
| 11/2011 | Leho | Venture Round | 50M |
| 4/2007 | Huan Xiong | Venture Round | 1.8M |
| 8/2015 | Tuhu | Series C | 0 |
| 7/2017 | OPUS | Angel Round | 1M |
| 10/2017 | Jacobio Pharmaceuticals | Venture Round | 19.6M |
| 4/2022 | Clique | Seed Round | - |
| 4/2016 | Xueda | Post-IPO Equity | - |
| 12/2016 | MEGVII | Series C | 100M |
| 3/2016 | Lagou | Series C | 34M |
| 4/2011 | Dazhong Dianping | Series C | 100M |
| 9/2019 | TigerGraph | Series B | 32M |
| 1/2016 | Qiniu | Series D | 100M |
| 12/2019 | KeChow Pharma | Series C | 45M |
| 10/2020 | Broncus Technologies | Series C | - |
| 4/2018 | CMLabs | Series C | 15.9M |
| 4/2014 | Arrail Dental Clinic | Series C | 70M |
| 7/2021 | Zion Pharma | Series B | 40M |
| 4/2018 | Wuxi Vision Pro | Series B | 14.2M |
| 10/2013 | BSC | Series A | 1.6M |
| 10/2014 | WeDoctor | Series B | 106.5M |
| 7/2022 | PwnedNoMore | Seed Round | - |
| 4/2019 | Talaris Therapeutics | Series A | 100M |
| 12/2017 | QwikMatch | Series B | 6M |
| 2/2013 | Qiniu | Series B | 4.2M |
| 1/2017 | Microtech Medical | Series B | 12.2M |
| 11/2021 | Allorion Therapeutics | Series A | 0 |
| 6/2020 | Miaoshou Doctor | Series D | 85M |
| 10/2018 | NASN Automotive Electronics | Series A | 14.4M |
| 6/2019 | Liuyi Jiaoyu | Series B | 2.9M |
| 1/2017 | Xueba100.com | Series C | 100M |
| 2/2015 | Xueba100.com | Series B | 50M |
| 1/2022 | CureGenetics | Series B | 0 |
| 5/2015 | FraudMetrix | Series B | 30M |
| 1/2019 | Connect Biopharmaceuticals | Series B | 55M |
| 10/2018 | CardiaLen | Series B | 17M |
| 10/2020 | Cool Academy | Series A | 15M |
| 8/2021 | Berry Oncology | Series B | 99.2M |
| 7/2019 | Yuanxin Huibao | Series A | 7.3M |
| 6/2018 | WindMIL Therapeutics | Series B | 0 |
| 11/2018 | Cadent Therapeutics | Series B | 40M |
| 12/2014 | Wacai.com | Series B | 50M |
| 4/2019 | Mech-Mind | Series A | 50M |
| 3/2021 | Cool Academy | Series B | 18.9M |
| 6/2017 | MyHealthTeams | Series A | 7.3M |
| 1/2013 | Tuhu | Series A | - |
| 10/2008 | Novast | Series B | 50M |
| 2/2020 | Bouffalo Lab | Series B | 26M |
| 4/2018 | XSKY Data Technology | Series C | 37.8M |
| 6/2014 | Tujia | Series C | 100M |
| 9/2021 | Sunyur | Series B | 0 |
| 5/2020 | Alamar Biosciences | Series A | 14M |
| 10/2007 | Guokang Health Management | Series A | 10M |
| 8/2022 | GluBio Therapeutics | Series A | 22M |
| 9/2017 | Hypereal | Series C | 11.8M |
| 11/2017 | Berry Oncology | Series A | 121.2M |
| 4/2013 | Shenzhen LETEL Technology | Series A | 5.9M |
| 3/2018 | DST Car | Series A | 47.8M |
| 7/2021 | Insight Lifetech | Series D | 85M |
| 12/2020 | Insight Lifetech | Series C | 27.6M |
| 6/2018 | Xiaoy Technology | Series B | 4.7M |
| 9/2012 | Mafengwo | Series B | 15M |
| 11/2021 | ROX Motor | Series C | 100M |
| 1/2022 | Ceptur Therapeutics | Series A | 0 |
| 9/2011 | Beijing Centre Biology | Series A | 7.4M |
| 8/2018 | Nice Tuan | Seed Round | 0 |
| 9/2011 | Beva | Series A | 3.1M |
| 8/2018 | TUNGEE | Series A | 6.3M |
| 9/2015 | Wealth Bridge | Series C | - |
| 12/2014 | CANbridge Pharmaceuticals | Series A | 10M |
| 11/2020 | Asieris Pharmaceuticals | Series D | 0 |
| 8/2011 | Nurotron Biotechnology | Series B | 6.9M |
| 11/2014 | Nurotron Biotechnology | Series C | 1.2M |
| 3/2022 | Medilink Therapeutics | Series B | 70M |
| 3/2021 | imToken | Series B | 30M |
| 5/2008 | Oriental Cambridge Education Group | Venture Round | 1M |
| 10/2021 | ShouTi | Series B | 0 |
| 9/2018 | MicroPoint Bioscience | Series E | 109M |
| 3/2019 | RedDoorz | Series B | 0 |
| 4/2021 | SinoUnited Health Clinic | Series C | 30.7M |
| 1/2017 | Shenogen Pharma Group | Series D | 45M |
| 1/2023 | Yike Polymers | Series B | - |
| 8/2014 | Qiniu | Series C | - |
| 12/2018 | Microtech Medical | Series C | 29.1M |
| 1/2022 | WoXiaoYa | Series B | - |
| 6/2019 | Pratilipi | Series B | 15.2M |
| 10/2017 | Bang Er Orthopedic | Series C | 33.9M |
| 5/2019 | SinoUnited Health Clinic | Series B | 9.3M |
| 5/2018 | Heika | Series B | 10.3M |
| 6/2017 | Miaoshou Doctor | Series B | 10.9M |
| 7/2019 | Dingdong Maicai | Series B | - |
| 3/2016 | JHT TCM Clinics | Series B | 1.5M |
| 4/2019 | INXX | Series B | 16.5M |
| 2/2019 | Zuiyou | Series C | 80M |
| 11/2015 | ET Healthcare | Series B | - |
| 3/2018 | Coffee Box | Series B | 88M |
| 12/2019 | Newsoara | Series B | 22M |
| 6/2016 | CMLabs | Series B | 14.1M |
| 4/2021 | Alpha Biopharma | Series B | 25M |
| 1/2017 | Qkuts | Seed Round | 1M |
| 8/2018 | ANXIN | Series B | 19.1M |
| 7/2008 | Tigermed | Series A | 6.3M |
| 2/2016 | Microtech Medical | Series A | 24.3M |
| 3/2019 | LuPu Investment | Series A | 44.6M |
| 12/2014 | Luoji Siwei | Series A | - |
| 7/2017 | Sino Biological | Series A | 29.4M |
| 3/2016 | Seven Kilometers | Series A | 5M |
| 12/2014 | SequoiaDB | Series A | 10M |
| 3/2014 | Sanyou Medical | Series A | - |
| 3/2010 | Arrail Dental Clinic | Series A | 20M |
| 6/2018 | Pop Game | Seed Round | - |
| 8/2021 | Neuro3 Therapeutics | Seed Round | 10M |
| 4/2018 | Meituan | Venture Round | - |
| 11/2013 | Meitu | Seed Round | 5M |
| 11/2021 | Bioyond Tech | Seed Round | 7.8M |
| 12/2021 | Frontis | Seed Round | 18.4M |
| 4/2020 | Cadent Therapeutics | Series B | 15M |
| 5/2013 | Berry Genomics | Series B | 14.7M |
| 7/2020 | XSKY Data Technology | Series D | 33M |
| 12/2019 | SinoUnited Health Clinic | Series C | 8.1M |
| 8/2010 | eHi Car Rental | Series C | 70M |
| 7/2016 | SequoiaDB | Series B | 10M |
| 11/2021 | Platelet BioGenesis | Series B | 75.5M |
| 1/2008 | 9DIAMOND | Series A | 9.6M |
| 4/2022 | CIX Technology | Angel Round | - |
| 2/2020 | InfStones | Series A | 10M |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 7/2018 | Madaket | Series B | 0 |
| 1/2021 | Vistel | Series B | 9.3M |
| 7/2015 | Zhaolu Tianxia Wang | Series B | 3.2M |
| 5/2017 | Wacai.com | Series C | 0 |
| 6/2006 | Fangtek | Series C | 12M |
| 1/2015 | Bilibili | Series B | 44.2M |
| 12/2020 | WT Microtech Medical | Series D | 0 |
| 1/2015 | Zhaosuliao | Series A | 20M |
| 12/2015 | HyperStrong | Series A | 20.3M |
| 7/2017 | Akulaku | Series B | 24.8M |
| 6/2018 | Ark Biosciences | Series B | 32M |
| 7/2015 | Wacai.com | Series B | 80M |
| 4/2016 | ACEA BIO | Series E | 6M |
| 5/2014 | Crown Bioscience | Series D | 26.6M |
| 8/2020 | Connect Biopharmaceuticals | Series C | 115M |
| 1/2023 | Biotree | Series A | - |
| 2/2017 | Ark Biosciences | Series A | 8M |
| 3/2013 | Origene Technologies | Series C | 21.3M |
| 6/2014 | MOGU | Series D | 200M |
| 9/2021 | XellSmart | Seed Round | 11.9M |
| 4/2021 | Gaugene | Series A | 4.6M |
| 4/2019 | Coffee Box | Series B | 30.6M |
| 3/2015 | Mafengwo | Series C | 100M |
| 1/2017 | Zhihu | Series D | 103.3M |
| 11/2011 | Zhihu | Series A | 8M |
| 7/2018 | Moretickets | Series C | 61.7M |
| 1/2022 | EigenCOMM | Series C | 157.3M |
| 10/2019 | dMed | Series B | 50M |
| 11/2018 | WorkTrans | Series B | 23M |
| 8/2021 | Matrixport | Series C | 0 |
| 1/2021 | WeRide | Series B | 0 |
| 1/2019 | NASN Automotive Electronics | Series B | 59.6M |
| 8/2013 | Shenogen Pharma Group | Series C | 20M |
| 9/2008 | ChinaCache | Series C | - |
| 5/2019 | ZuzuChe | Series C | 26.1M |
| 7/2011 | Fanli | Series A | 10M |
| 5/2021 | Valgen Medtech | Series B | 188M |
| 9/2019 | DST Car | Venture Round | 30M |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 9/2020 | InventisBio | Series D | 0 |
| 7/2022 | Ark Biosciences | Series D | - |
| 11/2015 | ACEA BIO | Venture Round | 30M |
| 3/2019 | Abbisko Therapeutics | Series B | 42M |
| 5/2016 | Bilibili | Series C | 199.3M |
| 12/2016 | WT Microtech Medical | Series B | - |
| 4/2016 | Insta360 | Series B | - |
| 7/2011 | Xiaomi | Series A | 41M |
| 12/2011 | Xiaomi | Series B | 90M |
| 11/2017 | Twine Health | Series A | 1.5M |
| 4/2008 | Nurien Software | Series A | 15M |
| 5/2016 | Musical.ly | Series C | 133.5M |
| 7/2011 | VANCL | Series F | 230M |
| 7/2015 | Tiebaobei | Series B | 16.2M |
| 4/2021 | Axera | Seed Round | - |
| 11/2013 | Tiebaobei | Series A | - |
| 10/2021 | Clounix | Angel Round | - |
| 5/2017 | Sinocelltech | Series A | 29M |
| 1/2022 | Zhenge Biotech | Series C | 100M |
| 12/2014 | Meitu | Series C | 190M |
| 11/2021 | GenEdit | Angel Round | 9M |
| 11/2019 | Genius | Series B | 14.2M |
| 7/2021 | Petkit | Series D | 60M |
| 4/2021 | Abogen Biosciences | Series B | 91.6M |
| 2/2019 | Petkit | Series C | 20M |
| 6/2021 | Hesai Technology | Series D | 300M |
| 2/2023 | Oricell Therapeutics | Series B | 0 |
| 9/2020 | Petkit | Series C | - |
| 8/2019 | MyHealthTeams | Series B | 0 |
| 2/2014 | ITutorGroup | Series B | 100M |
| 10/2015 | CANbridge Pharmaceuticals | Series A | 10M |
| 3/2018 | LetsGetChecked | Series A | 12M |
| 1/2019 | Antengene Corporation | Series B | 0 |
| 6/2009 | Novast | Series B | 25M |
| 1/2009 | Nurien Software | Series A | 10M |
| 6/2012 | Xiaomi | Series C | 216M |
| 4/2019 | Structure Therapeutics | Series A | 16M |
| 3/2023 | TandemAI | Series A | 0 |
| 6/2017 | Zai Lab | Series C | 30M |
| 7/2017 | Kezar Life Sciences | Series B | 0 |
| 7/2022 | Gaugene | Series B | 0 |
| 8/2021 | Abogen Biosciences | Series C | 0 |
| 1/2021 | Abbisko Therapeutics | Series D | 123M |
| 2/2022 | GluBio Therapeutics | Series A | 0 |
| 11/2015 | CanSinoBIO | Series C | 30M |
| 10/2021 | Structure Therapeutics | Series B | 0 |
| 2/2017 | Jacobio Pharmaceuticals | Series B | - |
| 4/2023 | Bioyond Tech | Series A | 0 |
| 9/2022 | XellSmart | Series A | - |
| 1/2019 | Schrödinger | Series E | 0 |
| 12/2017 | Tiebaobei | Series C | - |
| 9/2018 | SequoiaDB | Series C | 0 |
| 8/2022 | OriginCell | Series B | 0 |
| 12/2019 | OriginCell | Series A | 7.1M |
| 2/2021 | Liangyihui | Series C | 0 |
| 8/2017 | New Horizon Health | Series B | 20M |
| 1/2023 | Singular Medical | Series B | - |
| 11/2018 | Genor Biopharma | Venture Round | 276.7M |
| 3/2020 | Abbisko Therapeutics | Series C | 70M |
| 12/2016 | Shulan Health | Series B | 31.2M |
| 12/2019 | Clinflash Heathcare Technology | Series A | 4.3M |
| 3/2020 | Xueba100.com | Convertible Note | 22.7M |
| 9/2019 | Hesai Technology | Series C | 1.1M |
| 10/2008 | T4GAME | Series A | 3M |
| 1/2010 | YPX Cayman Holdings | Series A | 10M |
| 3/2021 | IntoCare | Secondary Market | 4.3M |
| 6/2015 | Cehome | Series B | 2.5M |
| 5/2014 | Broncus Technologies | Venture Round | 4.3M |
| 12/2016 | Finern | Series A | 7.3M |
| 3/2020 | ShouTi | Series A | 26M |
| 1/2016 | HyperStrong | Series B | 68.5M |
| 6/2021 | BrainHealth | Series C | 72.4M |
| 12/2018 | Xiudan | Seed Round | 3M |
| 2/2021 | Wholee | Series A | 10k |
| 3/2015 | Bioon.com | Series A | 2.9M |
| 12/2021 | Clinflash Heathcare Technology | Venture Round | 15.5M |
| 5/2018 | Bang Er Orthopedic | Series C | 15.8M |
| 6/2022 | Insilico Medicine | Series D | 0 |
| 4/2018 | KangBai | Series A | 3.7M |
| 3/2021 | Basecamp Bio | Angel Round | 14M |
| 12/2021 | Sinogen Biopharma | Venture Round | 3M |
| 9/2021 | ROX Motor | Series B | 60M |
| 5/2019 | Zaojiu | Venture Round | 2M |
| 5/2017 | DST Car | Seed Round | 7.3M |
| 8/2021 | Yunqi | Seed Round | 31M |
| 7/2013 | Hortor | Series A | 2.5M |
| 11/2018 | Mucho Indonesia | Seed Round | 3M |
| 12/2011 | Beijing GoodWill Technology | Series A | 4.2M |
| 11/2018 | Webuy Group | Series B | 15.8M |
| 10/2015 | Wuxi Vision Pro | Series A | 4.8M |
| 8/2016 | Xiutao | Seed Round | 1.5M |
| 11/2018 | WebComics | Seed Round | 3.2M |
| 8/2021 | Lingyi Zhihui | Series B | 0 |
| 12/2019 | Inbilin | Venture Round | - |
| 3/2018 | V Light | Seed Round | 1M |
| 9/2019 | Plum | Series B | 0 |
| 9/2018 | Aohua | Series D | 43.7M |
| 1/2016 | Aohua | Series C | 30.8M |
| 7/2015 | Lanmi | Series A | 5M |
| 6/2013 | VINNO Technology | Series A | 5.8M |
| 4/2022 | Rhino Health | Venture Round | 5.7M |
| 7/2020 | New Horizon Health | Series E | 30M |
| 8/2017 | Antengene Corporation | Series A | 21M |
| 1/2020 | Chushou | Debt Financing | 4M |
| 7/2018 | dMed | Series B | 6M |
| 3/2019 | ACEA BIO | Venture Round | 20M |
| 8/2022 | GluBio Therapeutics | Series A | 0 |
| 8/2022 | OriginCell | Series B | 0 |
| 8/2022 | Oricell Therapeutics | Series B | 0 |
| 7/2022 | Chatail | Series B | 0 |
| 7/2022 | CIX Technology | Seed Round | - |
| 7/2022 | Biotree | Series A | 0 |
| 7/2022 | Gaugene | Series B | 0 |
| 7/2022 | Ark Biosciences | Series D | - |
| 6/2022 | LaNova Medicines | Series B | - |
| 6/2022 | Insilico Medicine | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
